Covance Clinical Development (Phase I-III) Service
Your product development plans deserve the best integrated program of research services available - so choose Covance. With pressure to substantially increase numbers of trial participants, increased scrutiny on product safety and stringent regulatory controls throughout the world, Covance is ready to partner and bring to the fore the expertise, resources and insight required to guide you through the complex and challenging c…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Your product development plans deserve the best integrated program of research services available - so choose Covance.
With pressure to substantially increase numbers of trial participants, increased scrutiny on product safety and stringent regulatory controls throughout the world, Covance is ready to partner and bring to the fore the expertise, resources and insight required to guide you through the complex and challenging course of biopharmaceutical development.
Our integrated clinical development services are unique to Covance. Acquire the global reach and therapeutic record of success from one of the few truly global drug development companies positioned to provide comprehensive clinical support from First-in-Human studies through pivotal Phase III global clinical trials.
7 Ways to Reduce Inflammation Study Challenges
The following whitepaper offers seven approaches recommended by Covance to reduce common inflammation clinical study challenges. These proactive approaches are based on our experience carrying out clinical trials in this area, as well as an acknowledgement that the re-applicability of therapies to different Immune-Mediated Inflammatory Disorders (IMIDs) also enables operational improvements to the conduct of IMID clinical trials.
